𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Does Pharmacogenomics Account for Variability in Control of Acute Chemotherapy-Induced Nausea and Vomiting with 5-Hydroxytryptamine Type 3 Receptor Antagonists?

✍ Scribed by Trammel, Morgan; Roederer, Mary; Patel, Jai; McLeod, Howard

Book ID
120077085
Publisher
Current Science Inc.
Year
2013
Tongue
English
Weight
279 KB
Volume
15
Category
Article
ISSN
1523-3790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

5-hydroxytryptamine type-3 receptor anta
5-hydroxytryptamine type-3 receptor antagonists for chemotherapy-induced and radiotherapy-induced nausea and emesis : Can we safely reduce the dose of administered agents?
✍ Matti Aapro; Peter Blower πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 223 KB

Supported by Roche Laboratories. Dr. Blower has acted as a consultant to Glaxo-SmithKline, Novartis Pharma, and Hoffman-La Roche Laboratories and is a stockholder for Glaxo-SmithKline. Dr. Aapro has acted as a consultant for Roche Laboratories, Helsinn, Novartis Pharma, and Aventis, all of which a